Use of orally administered anhydrous crystalline maltose for relief of dry mouth.

OBJECTIVES To examine the safety and efficacy of anhydrous crystalline maltose (ACM) for treatment of dry mouth. DESIGN ACM was delivered orally as a 200-mg lozenge given three times daily over a 12-week (study Alpha) or 24-week (study Omega) period to a total of 22 and 97 subjects, respectively. All participants had prominent complaints of persistent dry mouth associated with primary Sjögren's syndrome. Patients were examined every 4 weeks in study Alpha and every 6 weeks in study Omega. SETTINGS Patients were seen in outpatient clinics at a total of 33 sites within the United States. OUTCOME MEASURES Unstimulated whole saliva output, a measure of basal salivary gland function, was determined at each visit. Symptoms associated with oral and ocular dryness were assessed at the same time with the use of 100-mm visual analog scales. Safety was assessed by physical examination and laboratory studies. RESULTS During these clinical trials, a majority of subjects demonstrated an increase in unstimulated whole saliva output and the treatment exhibited an excellent safety profile. The ACM treatment in study Omega led to significant improvement in several subjective measures of oral and ocular comfort. CONCLUSIONS In these two studies, ACM lozenges administered three times daily for 12 or 24 weeks improved salivary output and decreased complaints of dry mouth and eyes. Side effects were minimal, and treatment was without significant adverse events. This safe and simple intervention may provide clinical benefit to individuals with distressing dry mouth symptoms.

[1]  P. Fox,et al.  A third study on the use of orally administered anhydrous crystalline maltose for relief of dry mouth in primary Sjögren's syndrome. , 2002, Journal of alternative and complementary medicine.

[2]  J. Kronenberg,et al.  Salivary flow and its relation with oral symptoms in terminally ill patients , 2000, Cancer.

[3]  R. Fox,et al.  Sjögren's syndrome. , 1994, Clinics in dermatology.

[4]  P. Fox.  Management of dry mouth. , 1997, Dental clinics of North America.

[5]  T. Maruyama,et al.  Pathogenesis and treatment of Sjögren's syndrome. , 1997, Current opinion in rheumatology.

[6]  R. Fox.  Sjögren's syndrome. Controversies and progress. , 1997, Clinics in laboratory medicine.

[7]  J. Rivera,et al.  Rheumatologic and autoimmune manifestations in patients with chronic hepatitis C virus infection. , 1997, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[8]  K. Forbes.  Palliative care in patients with cancer of the head and neck. , 1997, Clinical otolaryngology and allied sciences.

[9]  N. Diamant,et al.  Primary Biliary Cirrhosis, Sicca Complex, and Dysphagia , 1997, Dysphagia.

[10]  R. Fox,et al.  Clinical features, pathogenesis, and treatment of Sjögren's syndrome. , 1996, Current opinion in rheumatology.

[11]  T. Daniels.  Sjögren's Syndrome: Clinical Spectrum and Current Diagnostic Controversies , 1996, Advances in dental research.

[12]  Y. Shoenfeld,et al.  Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. , 1996, Annals of the rheumatic diseases.

[13]  R. Mulligan,et al.  A pilot study comparing three salivary collection methods in an adult population with salivary gland hypofunction. , 1995, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

[14]  A. P. Burtner,et al.  Oral side-effects of the most frequently prescribed drugs. , 1994, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

[15]  G. Gilbert,et al.  Mouth dryness as reported by older Floridians. , 1993, Community dentistry and oral epidemiology.

[16]  M. Navazesh,et al.  Methods for Collecting Saliva , 1993, Annals of the New York Academy of Sciences.

[17]  D. Locker.  Subjective reports of oral dryness in an older adult population. , 1993, Community dentistry and oral epidemiology.

[18]  P. Fox,et al.  Sjogren's syndrome: oral and dental considerations. , 1993, Journal of the American Dental Association.

[19]  D. Isenberg,et al.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. , 1993, Arthritis and rheumatism.

[20]  Friedlaender Mh.  Ocular manifestations of Sjögren's syndrome: keratoconjunctivitis sicca. , 1992, Rheumatic diseases clinics of North America.

[21]  D. Myssiorek,et al.  Primary Salivary Gland Amyloidosis Causing Sicca Syndrome , 1992, The Annals of otology, rhinology, and laryngology.

[22]  K. Izutsu,et al.  Differences in salivary flow rates in elderly subjects using xerostomatic medications. , 1991, Oral surgery, oral medicine, and oral pathology.

[23]  Butt Gm.  Drug-induced xerostomia. , 1991 .

[24]  L. West,et al.  Dental management of the patient with major depression. , 1991, Oral surgery, oral medicine, and oral pathology.

[25]  K. Karlsson,et al.  Glycobiology: a growing field for drug design. , 1991, Trends in pharmacological sciences.

[26]  C. Jacobs.  The internist in the management of head and neck cancer. , 1990, Annals of internal medicine.

[27]  Stefaniotis Td,et al.  [Incidence of xerostomia in patients with drug-controlled diabetes mellitus]. , 1990 .

[28]  N. Sharon,et al.  Lectins as cell recognition molecules. , 1989, Science.

[29]  C. Papadimitriou,et al.  Prevalence of primary Sjögren's syndrome in an elderly population. , 1988, British journal of rheumatology.

[30]  R. Strickland,et al.  The frequency of sicca syndrome in an elderly female population. , 1987, The Journal of rheumatology.

[31]  M. Fritzler,et al.  Antinuclear, anticytoplasmic, and anti-Sjogren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors. , 1985, Clinical immunology and immunopathology.

[32]  B. Sonies,et al.  Xerostomia: evaluation of a symptom with increasing significance. , 1985, Journal of the American Dental Association.

[33]  R. Bone,et al.  Primary Sjogren syndrome: clinical and immunopathologic features. , 1984, Seminars in arthritis and rheumatism.

[34]  N. Sharon,et al.  Lectin receptors as lymphocyte surface markers. , 1983, Advances in immunology.

[35]  S. Sonis,et al.  Oral complications of cancer chemotherapy: present status and future studies. , 1982, Cancer treatment reports.